Progyny (PGNY) Set to Announce Earnings on Tuesday

Progyny (NASDAQ:PGNY - Get Free Report) is set to announce its earnings results after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of $0.37 per share for the quarter. Investors that wish to listen to the company's earnings conference call can do so using this link.

Progyny (NASDAQ:PGNY - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.17 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.17. The business had revenue of $304.09 million for the quarter, compared to analyst estimates of $305.32 million. Progyny had a net margin of 5.54% and a return on equity of 11.97%. The business's revenue was up 8.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.15 earnings per share. On average, analysts expect Progyny to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Progyny Trading Up 4.2 %

Shares of NASDAQ:PGNY traded up $0.64 during midday trading on Tuesday, hitting $15.79. 1,137,222 shares of the stock were exchanged, compared to its average volume of 1,371,524. The company has a 50 day moving average price of $18.61 and a 200-day moving average price of $24.30. The stock has a market cap of $1.43 billion, a P/E ratio of 24.84, a PEG ratio of 1.41 and a beta of 1.44. Progyny has a twelve month low of $13.93 and a twelve month high of $42.08.

Analysts Set New Price Targets

A number of research firms have recently commented on PGNY. JPMorgan Chase & Co. dropped their price objective on shares of Progyny from $31.00 to $22.00 and set an "overweight" rating for the company in a research note on Thursday, September 19th. BTIG Research cut Progyny from a "buy" rating to a "neutral" rating in a report on Wednesday, August 7th. JMP Securities cut Progyny from an "outperform" rating to a "market perform" rating in a report on Thursday, September 19th. Truist Financial reduced their target price on Progyny from $33.00 to $26.00 and set a "buy" rating for the company in a research note on Thursday, September 19th. Finally, Canaccord Genuity Group cut Progyny from a "buy" rating to a "hold" rating and reduced their target price for the company from $37.00 to $24.00 in a research note on Wednesday, August 7th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $27.73.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.